VITRECTOMY FOR PERSISTENT MACULAR HOLES FOLLOWING OCRIPLASMIN INJECTION: A Comparative Multicenter Study

Purpose: To determine functional and anatomical outcomes of pars plana vitrectomy for persistent full-thickness macular hole (MH) after intravitreal injection of ocriplasmin. Methods: This is a multicenter retrospective interventional study of 37 eyes of 37 patients who underwent pars plana vitrectomy with internal limiting membrane peeling for persistent MH after ocriplasmin treatment between December 2013 and December 2015 and comparison with 35 eyes of 35 patients who were offered ocriplasmin injection but underwent pars plana vitrectomy alone without pharmacologic vitreolysis before surgery. In addition, 24 matched pairs (MH diameter at baseline ±5 µm) were analyzed. Clinical data such as visual acuity, intraoperative characteristics, and spectral domain optical coherence tomography images were reviewed. Main outcome measures were visual acuity and MH closure rate. Results: After a mean follow-up period of 9 months, postoperative mean visual acuity showed no significant differences between ocriplasmin-treated eyes (logarithm of minimum angle of resolution 0.37 ± 0.26, Snellen 20/47) and eyes without ocriplasmin treatment (logarithm of minimum angle of resolution 0.39 ± 0.25; Snellen 20/49) (P > 0.9). After ocriplasmin injection, mean MH diameter enlarged from 217 ± 102 µm to 384 ± 239 µm (P < 0.001). Matched-pair analysis revealed no difference in gain of visual acuity between the first visit and the last follow-up (P = 0.29). Macular hole closure was observed in similar proportion in ocriplasmin-treated eyes (97%) and vitrectomy-only eyes (94%) (P > 0.5). Conlcusion: Eyes with persistent MH after ocriplasmin injection showed significant visual improvement after pars plana vitrectomy. Matched-pair analysis revealed no statistical differences in functional and anatomical postoperative results comparing with eyes of similar MH diameter that proceeded directly to surgery without ocriplasmin pretreatment.

[1]  E. Rahimy,et al.  IMPACT OF INTERNAL LIMITING MEMBRANE PEELING ON MACULAR HOLE REOPENING: A Systematic Review and Meta-Analysis , 2016, Retina.

[2]  George A. Williams,et al.  RESOLUTION OF SUBRETINAL FLUID AND OUTER RETINAL CHANGES IN PATIENTS TREATED WITH OCRIPLASMIN , 2016, Retina.

[3]  Margaret A. Greven,et al.  Vitrectomy After ocriplasmin for VitreOmacular adhesion Or Macular hole (VAVOOM) study , 2015, British Journal of Ophthalmology.

[4]  M. Maier,et al.  [Ocriplasmin as a treatment option for symptomatic vitreomacular traction with and without macular hole. First clinical experiences]. , 2015, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[5]  A. Kampik,et al.  Pathology of Internal Limiting Membrane Specimens Following Intravitreal Injection of Ocriplasmin. , 2015, American journal of ophthalmology.

[6]  J. Duker,et al.  Surgical Outcomes for Persistent Macular Hole After Ocriplasmin. , 2015, Ophthalmic surgery, lasers & imaging retina.

[7]  M. Maier,et al.  Ocriplasmin zur Behandlung der symptomatischen vitreomakulären Traktion mit und ohne Makulaforamen , 2015, Der Ophthalmologe.

[8]  I. Stalmans,et al.  IMPROVED EFFICACY OF OCRIPLASMIN FOR VITREOMACULAR TRACTION RELEASE AND TRANSIENT CHANGES IN OPTIC DISK MORPHOLOGY , 2015, Retina.

[9]  M. Sandinha,et al.  The Plane of Vitreoretinal Separation and Results of Vitrectomy Surgery in Patients Given Ocriplasmin for Idiopathic Macular Hole. , 2015, Investigative ophthalmology & visual science.

[10]  A. Kampik,et al.  Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials. , 2015, Ophthalmology.

[11]  N. Scott,et al.  Vitrectomy with internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole. , 2014, Ophthalmology.

[12]  Peter Stalmans,et al.  OCT-BASED INTERPRETATION OF THE VITREOMACULAR INTERFACE AND INDICATIONS FOR PHARMACOLOGIC VITREOLYSIS , 2013, Retina.

[13]  J. Duker,et al.  Ocriplasmin: a medical or surgical therapy? , 2013, Retina.

[14]  J. Roider,et al.  Aktuelle Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augenärzte Deutschlands zur therapeutischen intravitrealen Anwendung von Ocriplasmin (JETREA®) in der Augenheilkunde (Stand Mai 2013) , 2013, Klin Monatsbl Augenheilkd.

[15]  N. Eter,et al.  [Current Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for therapeutic intravitreal application of Ocriplasmin (JETREA ®) in ophthalmology (May 2013)]. , 2013, Klinische Monatsblatter fur Augenheilkunde.

[16]  A. Kampik,et al.  Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. , 2012, The New England journal of medicine.

[17]  F. Folgar,et al.  Macular hole surgery prognostic success rates based on macular hole size. , 2012, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[18]  B. Dlouhy,et al.  Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. , 2012, The New England journal of medicine.

[19]  T. Williamson,et al.  Predicting visual success in macular hole surgery , 2009, British Journal of Ophthalmology.

[20]  Edgar Erdfelder,et al.  G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.

[21]  S. Priglinger,et al.  FIVE-YEAR FOLLOW-UP OF MACULAR HOLE SURGERY WITH PEELING OF THE INTERNAL LIMITING MEMBRANE: Update of a Prospective Study , 2006, Retina.

[22]  P. Massin,et al.  Relationship between macular hole size and the potential benefit of internal limiting membrane peeling , 2006, British Journal of Ophthalmology.

[23]  J Castro Navarro,et al.  [Macular hole surgery with and without internal limiting membrane peeling]. , 2003, Archivos de la Sociedad Espanola de Oftalmologia.

[24]  Christos Haritoglou,et al.  Long-term follow-up after macular hole surgery with internal limiting membrane peeling. , 2002, American journal of ophthalmology.

[25]  M. Kondo,et al.  Focal macular ERGs in eyes after removal of macular ILM during macular hole surgery. , 2001, Investigative ophthalmology & visual science.